← Contracts
PT
Ajuste direto para aquisição de T1140 - TRIPTORRELINA (PÓ P/ SOL INJ) [0.1 MG/ML; 1 ML; FRS] e T202 - TRIPTORRELINA (PÓ P/ SUSP INJ) [3,75MG; FRS/ SERINGA] para suprir necessidades na área da saúde.
ID 12877042
· Portal BASE
Price
Base Price
€18,450
.00
Effective Price
€964
.00
-94.8%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Porto, Porto
- Bidder Count
- —
Winner
IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.
NIF 502609800
Dates
- Publication
- 26 Jan 2026
- Celebration
- 23 Dec 2025
Contracting Entity
Unidade Local de Saúde de Santo António, EPE
NIF 517392259
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 100 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
- Authority
- 745
- Supplier
- 85
- Number of Awards
- 5
- Rule
- A1 repeat direct award: 5 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
- Publication Date
- 26 Jan 2026
- Signing Date
- 23 Dec 2025
- Days Late
- 34
- Rule
- A2/A3 late publication: 34 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 18450.0
- Total effective price
- 964.0
- Ratio
- 0.0522
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0522 outside [0.5, 1.5]
Detected 2026-03-06